Induction of OGG1 gene expression by HIV-1 Tat. (Q40414692)

20 September 2017

Induction of OGG1 gene expression by HIV-1 Tat. (English)

1 reference

20 September 2017

Kenichi Imai

1

1 reference

20 September 2017

Kenji Nakata

2

1 reference

20 September 2017

Kazuaki Kawai

3

1 reference

20 September 2017

Takaichi Hamano

4

1 reference

20 September 2017

Nan Mei

5

1 reference

20 September 2017

Hiroshi Kasai

6

1 reference

20 September 2017

Takashi Okamoto

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Journal of Biological Chemistry

20 September 2017

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 September 2017

280

1 reference

20 September 2017

26701-26713

1 reference

20 September 2017

29

1 reference

Control of RNA initiation and elongation at the HIV-1 promoter

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Tat trans-activates the human immunodeficiency virus through a nascent RNA target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Mutation pattern of human immunodeficiency virus gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

DNA deamination mediates innate immunity to retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

In search of a mutational hotspot

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Characterization of the hOGG1 promoter and its expression during the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Changes in levels of 8-hydroxyguanine in DNA, its repair and OGG1 mRNA in rat lungs after intratracheal administration of diesel exhaust particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Identification of ligands and coligands for the ecdysone-regulated gene switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

The p53 tumor suppressor targets a novel regulator of G protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

A novel approach to protein-protein interaction: complex formation between the p53 tumor suppressor and the HIV Tat proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Glutathione deficiency and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503313200

21 January 2018

Identifiers

DOI

10.1074/JBC.M503313200

1 reference

20 September 2017

1 reference